Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor
© 2018 Springer-Verlag GmbH Germany, part of Springer Nature Objectives: The present study is to investigate the salivary gland function of metabolic syndrome (MetS) patients, as indicated by salivary flow rate, amylase activity, and salivary oxidative stress, by measuring MDA level. Materials and m...
Saved in:
Main Authors: | Jitjiroj Ittichaicharoen, Arintaya Phrommintikul, Nipon Chattipakorn, Siriporn Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043368412&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/58609 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor
by: Jitjiroj Ittichaicharoen, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance
by: Jitjiroj Ittichaicharoen, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance
by: Jitjiroj Ittichaicharoen, et al.
Published: (2018) -
Energy restriction combined with dipeptidyl peptidase-4 inhibitor exerts neuroprotection in obese male rats
by: Hiranya Pintana, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control
by: Nipon Chattipakorn, et al.
Published: (2018)